116 related articles for article (PubMed ID: 18403107)
1. Life in the crypt: a role for glucagon-like peptide-2?
Rowland KJ; Brubaker PL
Mol Cell Endocrinol; 2008 Jun; 288(1-2):63-70. PubMed ID: 18403107
[TBL] [Abstract][Full Text] [Related]
2. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators.
Dubé PE; Brubaker PL
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E460-5. PubMed ID: 17652153
[TBL] [Abstract][Full Text] [Related]
3. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
[TBL] [Abstract][Full Text] [Related]
4. The "cryptic" mechanism of action of glucagon-like peptide-2.
Rowland KJ; Brubaker PL
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G1-8. PubMed ID: 21527727
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2.
Ivory CP; Wallace LE; McCafferty DM; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1202-10. PubMed ID: 18845573
[TBL] [Abstract][Full Text] [Related]
6. New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1).
Yu Z; Jin T
Cell Signal; 2010 Jan; 22(1):1-8. PubMed ID: 19772917
[TBL] [Abstract][Full Text] [Related]
7. ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut.
Yusta B; Holland D; Koehler JA; Maziarz M; Estall JL; Higgins R; Drucker DJ
Gastroenterology; 2009 Sep; 137(3):986-96. PubMed ID: 19523469
[TBL] [Abstract][Full Text] [Related]
8. Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines.
Sams A; Hastrup S; Andersen M; Thim L
Eur J Pharmacol; 2006 Feb; 532(1-2):18-23. PubMed ID: 16448646
[TBL] [Abstract][Full Text] [Related]
9. Sonic hedgehog and bone morphogenetic protein-4 signaling pathway involved in epithelial cell renewal along the radial axis of the intestine.
Ishizuya-Oka A; Hasebe T
Digestion; 2008; 77 Suppl 1():42-7. PubMed ID: 18204261
[TBL] [Abstract][Full Text] [Related]
10. Current view: intestinal stem cells and signaling.
Scoville DH; Sato T; He XC; Li L
Gastroenterology; 2008 Mar; 134(3):849-64. PubMed ID: 18325394
[TBL] [Abstract][Full Text] [Related]
11. Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine.
Anini Y; Izzo A; Oudit GY; Backx PH; Brubaker PL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1599-606. PubMed ID: 17284578
[TBL] [Abstract][Full Text] [Related]
12. The glucagon-like peptides: pleiotropic regulators of nutrient homeostasis.
Brubaker PL
Ann N Y Acad Sci; 2006 Jul; 1070():10-26. PubMed ID: 16888147
[TBL] [Abstract][Full Text] [Related]
13. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.
Kaji T; Tanaka H; Redstone H; Wallace LE; Holst JJ; Sigalet DL
J Surg Res; 2009 Apr; 152(2):271-80. PubMed ID: 19062041
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-2: divergent signaling pathways.
Rocha FG; Shen KR; Jasleen J; Tavakkolizadeh A; Zinner MJ; Whang EE; Ashley SW
J Surg Res; 2004 Sep; 121(1):5-12. PubMed ID: 15313368
[TBL] [Abstract][Full Text] [Related]
15. Adenomatous polyposis coli regulates Drosophila intestinal stem cell proliferation.
Lee WC; Beebe K; Sudmeier L; Micchelli CA
Development; 2009 Jul; 136(13):2255-64. PubMed ID: 19502486
[TBL] [Abstract][Full Text] [Related]
16. [Transfection and identification of the cloned strain that stably expressing glucagon like peptide-2 receptor in CaCO2 cell lines].
Zhao Y; Wang FJ; Wang P; Qi HB; Wang SL
Zhonghua Shao Shang Za Zhi; 2006 Aug; 22(4):258-61. PubMed ID: 17175639
[TBL] [Abstract][Full Text] [Related]
17. Intestinal morphogenesis.
Rubin DC
Curr Opin Gastroenterol; 2007 Mar; 23(2):111-4. PubMed ID: 17268237
[TBL] [Abstract][Full Text] [Related]
18. GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation.
Fesler Z; Mitova E; Brubaker PL
Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32147716
[TBL] [Abstract][Full Text] [Related]
19. The use of GLP-2 and related growth factors in intestinal diseases.
Yazbeck R; Abbott CA; Howarth GS
Curr Opin Investig Drugs; 2010 Apr; 11(4):440-6. PubMed ID: 20336592
[TBL] [Abstract][Full Text] [Related]
20. Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2.
Cameron HL; Perdue MH
J Pharmacol Exp Ther; 2005 Jul; 314(1):214-20. PubMed ID: 15798004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
